Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Prognosis in Adult Patients With Congenital Heart Disease

Key facts

Who runs it
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Where
Rome, ItalySee the site
Trial code
Status
Recruiting
People taking part
450 people, planned
Started
21 Mar 2022
Expected to end
31 Dec 2026
Type of study
Observational
Record updated
9 December 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patients evaluated in our ACHD Outpatient Clinic between January 2014 and December 2026
  • Age ≥ 18 years

Who cannot take part

  • Patients without congenital heart disease confirmed during the first evaluation
  • Impossibility to retrieve information about the first clinical evaluation in our clinic from our electonic datasets
  • Follow up shorter than one-year
  • Refused consent to participate to the study

Where in Italy

  • Fondazione Policlinico Universitario Agostino GemelliRome, ItalyContact: Francesca Graziani, MD, PhDTaking people

About the trial

What the trial wants to find out

This is a mono-center observational ambispective study in which adult patients with congenital heart disease evaluated at our institution will be enrolled.

Read full original descriptionShow less

The primary endopoint is to assess the clinical and echocardiographic predictors of adverse events during follow-up (death, arrhythmias, cardiac hospitalization).

The secondary endpoints are: 1) evaluation of the incidence of the singular components of the primary endpoint; 2) evaluation of the prognostic impact of acquired lesions, including valve disease not present at birth; 3) need for surgical/percutaneous interventions during follow up.

Participants will be evaluated in the context of scheduled follow-up visits in our Outpatient ACHD Clinic. No interventions/drug administration will be performed other than those required by standard clinical practice.

The group in the trial

  • ACHD cohort

    Adult patients with congenital heart disease either untreated, corrected or palliated, evaluated in our ACHD Outpatient Clinic between 2014 and 2026 with at least one-year follow-up.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Prognosis in Adult Patients With Congenital Heart Disease: an Observational Study
Record updated
9 December 2024